"Glioblastoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
Descriptor ID |
D005909
|
MeSH Number(s) |
C04.557.465.625.600.380.080.335 C04.557.470.670.380.080.335 C04.557.580.625.600.380.080.335
|
Concept/Terms |
Glioblastoma- Glioblastoma
- Glioblastomas
- Astrocytoma, Grade IV
- Astrocytomas, Grade IV
- Grade IV Astrocytoma
- Grade IV Astrocytomas
Giant Cell Glioblastoma- Giant Cell Glioblastoma
- Giant Cell Glioblastomas
- Glioblastoma, Giant Cell
- Glioblastomas, Giant Cell
|
Below are MeSH descriptors whose meaning is more general than "Glioblastoma".
Below are MeSH descriptors whose meaning is more specific than "Glioblastoma".
This graph shows the total number of publications written about "Glioblastoma" by people in this website by year, and whether "Glioblastoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 7 | 2 | 9 |
1995 | 4 | 2 | 6 |
1996 | 9 | 6 | 15 |
1997 | 9 | 7 | 16 |
1998 | 7 | 6 | 13 |
1999 | 11 | 3 | 14 |
2000 | 7 | 2 | 9 |
2001 | 8 | 0 | 8 |
2002 | 7 | 2 | 9 |
2003 | 8 | 0 | 8 |
2004 | 9 | 3 | 12 |
2005 | 14 | 1 | 15 |
2006 | 15 | 3 | 18 |
2007 | 16 | 3 | 19 |
2008 | 25 | 7 | 32 |
2009 | 22 | 3 | 25 |
2010 | 36 | 9 | 45 |
2011 | 26 | 11 | 37 |
2012 | 47 | 4 | 51 |
2013 | 51 | 5 | 56 |
2014 | 50 | 3 | 53 |
2015 | 53 | 6 | 59 |
2016 | 42 | 3 | 45 |
2017 | 52 | 1 | 53 |
2018 | 41 | 4 | 45 |
2019 | 37 | 3 | 40 |
2020 | 38 | 2 | 40 |
2021 | 49 | 0 | 49 |
2022 | 33 | 0 | 33 |
2023 | 33 | 1 | 34 |
2024 | 11 | 0 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glioblastoma" by people in Profiles.
-
Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial. Nat Commun. 2024 Feb 23; 15(1):1650.
-
Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization. Sci Transl Med. 2024 Feb 14; 16(734):eadj5962.
-
Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy. Proc Natl Acad Sci U S A. 2024 Feb 20; 121(8):e2306973121.
-
Tumor-specific polycistronic miRNA delivered by engineered exosomes for the treatment of glioblastoma. Neuro Oncol. 2024 02 02; 26(2):236-250.
-
The genomic alterations in glioblastoma influence the levels of CSF metabolites. Acta Neuropathol Commun. 2024 Jan 19; 12(1):13.
-
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective. Cell. 2024 01 18; 187(2):446-463.e16.
-
GTP Signaling Links Metabolism, DNA Repair, and Responses to Genotoxic Stress. Cancer Discov. 2024 01 12; 14(1):158-175.
-
Targeting Innate Immunity in Glioma Therapy. Int J Mol Sci. 2024 Jan 12; 25(2).
-
Antigen-presenting B cells promote TCF-1+ PD1- stem-like CD8+ T-cell proliferation in glioblastoma. Front Immunol. 2023; 14:1295218.
-
Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics. Neuro Oncol. 2024 01 05; 26(1):127-136.